Recent Developments Sample Clauses
Recent Developments. As of the Effective Date, (a) all actions by each Company Entity necessary to authorize the execution, delivery and performance of the Transaction Documents have been taken (including the adoption of appropriate resolutions of the Governing Body), (b) no Event of Default has occurred, and (c) no Company Entity has incurred any additional Indebtedness since the Term Sheet Date.
Recent Developments. The financial information included the Registration Statement, the Disclosure Package and the Prospectus under the heading “[Summary—Recent Developments]” has been derived from the accounting records of the Company subject to internal controls, reflects and will reflect the Company’s best estimates of such information available to the Company as of the date hereof and as of each Closing Date, respectively, and, to the best of the Company’s knowledge and belief after due inquiry, is and will be accurate in all material respects as of such dates. If at any time following the date hereof there occurs an event or development as a result of which such financial information, if republished immediately following such event or development, would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, (i) the Company will promptly notify the Representative and (ii) the Company will promptly amend or supplement the Registration Statement, the Disclosure Package and/or the Prospectus to eliminate or correct such conflict, untrue statement or omission.
Recent Developments. Since the date hereof, there shall be no fact or circumstance (individually or in the aggregate) which constitutes a Material Adverse Change.
Recent Developments. On April 27, 2023, we sold 2,555,500 shares of the Company’s common stock at a price of $2.25 per share in an underwritten public offering. ThinkEquity LLC (“ThinkEquity”) served as underwriter of the offering. The aggregate net proceeds of the offering were approximately $5.1 million, after deducting underwriting discounts and estimated offering expenses. The shares of common stock were offered, issued and sold to the public pursuant to the Registration Statement on Form S-1, as amended from time to time (File No. 333-269606). We intend to use the net proceeds from the offering to fund the ongoing clinical trials of THIO, pre-clinical development of second-generation of telomere targeting compounds, and other research and development activities, as well as for working capital and other general corporate purposes. Concurrently with the closing of the public offering, we also issued warrants to purchase an aggregate of up to 127,775 shares of our common stock to ThinkEquity or its designees, at an exercise price of $2.8125 per share. These warrants are exercisable beginning on October 24, 2023, and expire on April 24, 2028, pursuant to the terms and conditions of the warrants. We were incorporated in Delaware in August 2018, and have operations in Chicago, Illinois, with some of our team members setup virtually and working remotely in California, Nevada and Florida, among others. Our principal executive office is located at ▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and our phone number is (▇▇▇) ▇▇▇-▇▇▇▇. In July 2021, we established a wholly-owned Australian subsidiary, MAIA Biotechnology Australia Pty Ltd., to conduct various preclinical and clinical activities for the development of our product candidates. In April 2022, we established a wholly owned Romanian subsidiary, MAIA Biotechnology Romania S.R.L. to conduct various preclinical and clinical activities for the development of our product candidates. Our website address is ▇▇▇.▇▇▇▇▇▇▇▇▇▇▇.▇▇▇. The information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information contained on, or that can be accessed through, our website as part of this prospectus or in deciding whether to purchase our securities.
Recent Developments. Intermedia -- WorldCom Merger On September 1, 2000, Intermedia entered into a merger agreement with WorldCom, Inc. Upon consummation of the merger, a subsidiary of WorldCom will be merged with and into Intermedia and Intermedia will become a subsidiary of WorldCom (the "Intermedia -- WorldCom Merger"). As a result of the merger, WorldCom will beneficially own a majority of the capital stock of Digex and will have voting control of Digex. The Federal Communications Commission approved the merger between WorldCom and Intermedia in January 2001 on the condition it comply with an agreement reached with antitrust authorities that WorldCom divest certain Intermedia assets and operations. On February 15, 2001, WorldCom, Intermedia and Digex announced a proposed settlement (the "Litigation Settlement") of a lawsuit arising out of WorldCom's planned acquisition of a controlling interest in Digex through the Intermedia -- WorldCom Merger. Certain of our minority shareholders brought suit to enjoin the merger or to invalidate the approval of the transaction by our Board of Directors. The proposed settlement would, if approved by the Delaware Chancery Court, fully resolve all claims in the lawsuit and permit the Intermedia -- WorldCom Merger to proceed. See Item 3 Legal Proceedings to Part I of this Form 10-K for the principal terms of the proposed settlement with respect to Digex. On Marc▇ ▇, ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ered into a definitive Stipulation of Settlement with all relevant parties to settle all claims related to a consolidated class action suit. The Court has entered its order directing that notice of the settlement be sent to proposed class members and has scheduled a final hearing to be held on April 6, 2001 in the Delaware Court of Chancery in Wilmington, Delaware. The final settlement of the suit is subject to the satisfaction of certain conditions as well as final court approval. Also on Marc▇ ▇, ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ certain subsidiaries of WorldCom entered into four commercial agreements. These commercial agreements will become effective at or before the consummation of the Intermedia -- WorldCom Merger pursuant to the merger agreement. The principal terms of the four commercial agreements are generally described as follows: - Sales Channel Agreement. Under this agreement, WorldCom will resell the Digex portfolio of managed Web hosting products. If Digex satisfies certain service level commitments, WorldCom agrees to purchase up to a total of $500.0 million during t...
Recent Developments. (a) Except as set forth in Section 2.10 of the Seller Disclosure Schedule, since the Most Recent Balance Sheet Date, there has been no change, event or circumstance that, individually or in the aggregate with all other changes, events or circumstances, has caused any Material Adverse Effect.
(b) Since the Most Recent Balance Sheet Date, the Company and each Subsidiary:
(i) has conducted the Subject Business only in the ordinary course and in substantially the same manner as conducted at the date hereof; (ii) has used its commercially reasonable efforts to preserve its business organization intact and to retain the services of its present officers, key employees and representatives; and (iii) used its commercially reasonable efforts to preserve its relationships with its employees, customers, suppliers and others having business relations with it.
(c) Since the Most Recent Balance Sheet Date, except as set forth in Section 2.10 of the Seller Disclosure Schedule, neither the Company nor any Subsidiary has: (i) authorized the issuance of, issued or permitted any change in, its share capital; (ii) permitted any of its assets to be subjected to any Lien other then Permitted Liens; (iii) sold, transferred or otherwise disposed of any material assets except in the ordinary course of business and consistent with past practice; (iv) made any capital expenditure or commitment therefore in excess of AUS $25,000; (v) except as expressly permitted by Article IV (and as disclosed in Section 4.1 of the Seller Disclosure Schedule), declared or paid any dividend or distribution in respect of its share capital or redeemed or repurchased any shares; (vi) increased its indebtedness for borrowed money except in the ordinary course of business and consistent with past practices; (vii) made any loan to any Person (other than intercompany loans and advances to employees for normal travel and entertainment expenses in a manner consistent with its past practices); (viii) entered into, amended or terminated any material contract to which it is a party except in the ordinary course of business and consistent with past practices; (ix) written off as uncollectible any notes or accounts receivable; (x) granted any increase in the rate of wages, salaries, bonuses or other remuneration of any employees other than in the ordinary course of business and consistent with past practices; (xi) adopted a new Employee Benefit Plan or terminated or amended any existing Employee Benefit Plan; (xii)...
Recent Developments. Except as set forth on Schedule 4.17, since April 30, 2004, to the Knowledge of the Seller there has not been and no fact or condition otherwise exists, which would be reasonably expected to cause any change which would have a Material Adverse Effect, other than changes in the ordinary course of business the effect of which, individually or in the aggregate, do not have a Material Adverse Effect.
Recent Developments. On February 2, 2021, we announced our financial results as of and for the quarter ended December 31, 2020 presented below. The consolidated financial results for the three months ended December 31, 2019 and 2020 and the nine months ended December 31, 2019 and 2020 included in this prospectus supplement have not been audited or reviewed by our independent registered public accounting firm, PricewaterhouseCoopers. Unless otherwise stated, all translations of RMB into US$ in this section titled ‘‘Recent Developments’’ were made at RMB6.5250 to US$1.00, the exchange rate on December 31, 2020 as set forth in the H.10 statistical release of the Federal Reserve Board, and all translations of RMB into HK$ were made at RMB0.84164 to HK$1.00, the middle rate on December 31, 2020 as published by the People’s Bank of China.
Recent Developments. On January 1, 2006, the Corporation completed its merger with MBNA Corporation.
Recent Developments. FinServ’s Restatement of Financial Statements